RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding

por Wauman, Joris, De Ceuninck, Leentje, Vanderroost, Nele, Lievens, Sam, Tavernier, Jan
Publicado 2011

Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies

por Huyghe, Leander, Van Parys, Alexander, Cauwels, Anje, Van Lint, Sandra, De Munter, Stijn, Bultinck, Jennyfer, Zabeau, Lennart, Hostens, Jeroen, Goethals, An, Vanderroost, Nele, Verhee, Annick, Uzé, Gilles, Kley, Niko, Peelman, Frank, Vandekerckhove, Bart, Brouckaert, Peter, Tavernier, Jan
Publicado 2020

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

por Van Lint, Sandra, Van Parys, Alexander, Van Den Eeckhout, Bram, Vandamme, Niels, Plaisance, Stephane, Verhee, Annick, Catteeuw, Dominiek, Rogge, Elke, De Geest, Jennifer, Vanderroost, Nele, Roels, Jana, Saeys, Yvan, Uzé, Gilles, Kley, Niko, Cauwels, Anje, Tavernier, Jan
Publicado 2023